Nab-paclitaxel (albumin-bound paclitaxel) and traditional paclitaxel are both used in pancreatic cancer treatment, but their adverse event (AE) profiles may differ due to formulation differences.
Jingtao Chen, Zhongliu Bian, Nan Qin
core +1 more source
Article on Cremophor-Free,Albumin-Bound Paclitaxel [PDF]
openaire +1 more source
Objective To prospectively explore efficacy and safety of radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer (CC).
Xiaohua Wu +5 more
core +1 more source
Population pharmacokinetics and pharmacodynamics of intraperitoneal aerosolized nanoparticle albumin-bound paclitaxel (nab-PTX) and metabolites. [PDF]
De Sutter PJ +10 more
europepmc +1 more source
Sintilimab Combined With Albumin-Bound Paclitaxel and SOX Regimen as Conversion Therapy for Unresectable Advanced Gastric Cancer Achieving Complete Remission: A Case Report and Literature Review. [PDF]
Tang Y +8 more
europepmc +1 more source
Prospective evaluation of dynamic changes in L3 skeletal muscle index and chemotherapy-induced peripheral neuropathy during albumin-bound paclitaxel chemotherapy. [PDF]
Yue M +11 more
europepmc +1 more source
Research Progress of Albumin-Bound Paclitaxel for Gastric Cancer
openaire +1 more source
A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer. [PDF]
Viniotis AF +20 more
europepmc +1 more source
Quality of life and psychological outcomes with albumin-bound paclitaxel-carboplatin versus solvent-based paclitaxel-carboplatin as first-line chemotherapy in stage IC-IV ovarian carcinoma. [PDF]
Mahlawat N, Sood A, Vias P, Sawaraj S.
europepmc +1 more source
Exploratory analysis of the association between body composition albumin-bound paclitaxel induced peripheral neuropathy. [PDF]
Jiang Y +8 more
europepmc +1 more source

